Variant report
Variant | nsv964548 |
---|---|
Chromosome Location | chr21:28265715-28275143 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GABPA-18 | chr21:28272099-28272312 | NONHSAT081550 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539674117 | chr21:28265822-28265823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148095228 | chr21:28265833-28265834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141885580 | chr21:28265843-28265844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184061991 | chr21:28265864-28265865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547834722 | chr21:28265877-28265878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557969547 | chr21:28265975-28265976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568167822 | chr21:28265995-28265996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540485205 | chr21:28271917-28271918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs162545 | chr21:28271978-28271979 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs530095328 | chr21:28271997-28271998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181629915 | chr21:28272006-28272007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533001900 | chr21:28272055-28272056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555809077 | chr21:28272070-28272071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186273186 | chr21:28272073-28272074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188590726 | chr21:28272081-28272082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548069967 | chr21:28272144-28272145 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs144060187 | chr21:28272227-28272228 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs551390075 | chr21:28272274-28272275 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs60216130 | chr21:28272283-28272284 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs162544 | chr21:28272317-28272318 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570775596 | chr21:28272332-28272333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs162543 | chr21:28272342-28272343 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs115738636 | chr21:28272351-28272352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550344521 | chr21:28272359-28272360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538376978 | chr21:28272364-28272365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371016900 | chr21:28272373-28272374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111541416 | chr21:28272470-28272471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185942545 | chr21:28272533-28272534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190856827 | chr21:28272575-28272576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2830576 | chr21:28272603-28272604 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs554012608 | chr21:28272621-28272622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577154835 | chr21:28272631-28272632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74970899 | chr21:28272652-28272653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562542225 | chr21:28272688-28272689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374884696 | chr21:28272704-28272705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs367843839 | chr21:28272724-28272725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11909535 | chr21:28272830-28272831 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs114652847 | chr21:28272834-28272835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2120633 | chr21:28272858-28272859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs57572860 | chr21:28272863-28272864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2120634 | chr21:28272910-28272911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs151063 | chr21:28272929-28272930 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs148675712 | chr21:28272950-28272951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570736731 | chr21:28272960-28272961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182201036 | chr21:28272964-28272965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538676189 | chr21:28272973-28272974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556921494 | chr21:28272983-28272984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs148717616 | chr21:28272984-28272985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186280082 | chr21:28272992-28272993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201156885 | chr21:28273046-28273047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:28265800-28266000 | Enhancers | Left Ventricle | heart |
2 | chr21:28271800-28272400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr21:28272200-28272400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr21:28272400-28273000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr21:28273000-28274600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr21:28273200-28273600 | Enhancers | Pancreas | Pancrea |
7 | chr21:28273800-28276000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr21:28274600-28275000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr21:28274800-28275000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr21:28274800-28276400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr21:28274800-28276600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr21:28275000-28276000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
13 | chr21:28275000-28276400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |